123I MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma - PubMed (original) (raw)

Case Reports

. 2008 Jan-Feb;10(1):19-23.

doi: 10.1007/s11307-007-0116-1. Epub 2007 Nov 2.

Affiliations

Case Reports

123I MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma

Andrei Iagaru et al. Mol Imaging Biol. 2008 Jan-Feb.

Abstract

Intraoperative gamma probe guidance has become widely utilized for sentinel lymph node dissection in patients with breast cancer and melanoma, using (99m)Tc sulfur colloid. However, new indications are possible and need to continue to be investigated. We report the use during a wedge liver biopsy of a new hand-held gamma probe designed for (123)I intraoperative guidance. The patient studied is a 5-year-old boy with history of stage 4 high-risk neuroblastoma. Anatomic imaging (CT, MRI), (99m)Tc bone scintigraphy and 2-deoxy-2-[F-18]fluoro-d-glucose-positron emission tomography/computed tomography (FDG-PET/CT) were negative, but the (123)I MIBG scintigraphy suggested recurrent liver disease. A decision was made to biopsy these lesions to obtain histopathological confirmation. Intraoperative gamma probe mapping of the liver identified areas with signal above the background, but these were prove to be hemosiderin deposits on histo-pathology examination.

PubMed Disclaimer

References

    1. Med Pediatr Oncol. 1997 Mar;28(3):171-4 -PubMed
    1. Crit Rev Comput Tomogr. 2003;44(1):47-61 -PubMed
    1. Semin Nucl Med. 2005 Apr;35(2):116-28 -PubMed
    1. J Nucl Med. 2004 Jul;45(7):1172-88 -PubMed
    1. J Pediatr Hematol Oncol. 1997 Sep-Oct;19(5):428-32 -PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources